AA

Abhisek Ajit Save

Director Additional Director DIN 03510775
DIN 03510775 First appointment Jun 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhisek Ajit Save

Data last updated:

Abhisek Ajit Save was an Additional Director at Almex Laboratories Private Limited (2011–2017) and Director at New Generation Chemical Private Limited (from 2011). The companies operate in Pharma.

DIN 03510775
Primary Designation Additional Director
Industry Pharma
First Appointment 25 Jun 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Almex Laboratories Private Limited U24230MH1990PTC056126
Additional Director01 Sep 20111990Active
Director25 Jun 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
New Generation Chemical Private Limited
Almex Laboratories Private Limited
Premium access

Shareholding and investment profile for Abhisek Ajit Save

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhisek Ajit Save

Abhisek Ajit Save was first appointed on 25 Jun 2011 as Director at New Generation Chemical Private Limited.

Abhisek Ajit Save held 2 earlier board appointments: Almex Laboratories Private Limited (Additional Director, 01 Sep 2011 to 11 May 2017); New Generation Chemical Private Limited (Director, from 25 Jun 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available